ArticleFrontiers in pharmacology2022

Ruxolitinib inhibits cytokine production by human lung macrophages without impairing phagocytic ability.

Nikola Mantov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.